Position in INCY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$427,304
-$15,778 QoQ
Shares Held
4,540
+1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROTHSCHILD INVESTMENT LLC holds $5,484,521 across 220 Biotechnology names. INCY ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,486 | $1,148,143 | |
| 2 | TECH |
BIO-TECHNE Corp
|
18,736 | $979,143 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
7,865 | $444,293 | |
| 4 | INCY |
Incyte Corp
This page
|
4,540 | $427,304 | |
| 5 | CGEN |
Compugen Ltd
|
140,600 | $299,478 | |
| 6 | EXEL |
Exelixis, Inc.
|
6,941 | $297,699 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
437 | $195,137 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
883 | $166,931 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $427,304 | 4,540 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $443,082 | 4,486 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $375,793 | 4,431 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $16,684 | 245 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $24,825 | 410 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $28,318 | 410 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $24,457 | 370 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $22,126 | 365 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $5,127 | 90 | Shares | Sole | 2024-07-31 | |
| 2023-12-31 | $2,197 | 35 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||